Overview
Extracellular traps (ETs) are a defense mechanism deployed by immune cells, notably neutrophils, to ensnare and kill invading pathogens. Discovered in 2004, ETs consist of a scaffold of chromatin fibers decorated with antimicrobial proteins. They are critical in combating bacterial, fungal, and viral infections. ET formation, termed ETosis, is a programmed cell death pathway distinct from apoptosis or necrosis. This process is triggered by pathogens, inflammatory cytokines, or chemical stimuli. Research highlights ETs' dual role: while protective, their overproduction can contribute to tissue damage in conditions like sepsis or lupus.
Key Features
ETs exhibit three hallmark components: nuclear or mitochondrial DNA as the structural backbone, histone proteins for stability, and granular enzymes like myeloperoxidase with microbicidal effects. Their sticky texture physically immobilizes pathogens while concentrating lethal doses of antimicrobial agents. Unique to ETs is their ability to act beyond the cell's lifespan, creating extracellular zones of pathogen control. Advanced imaging reveals their spiderweb-like morphology, which can span up to 15 micrometers. Recent studies also identify ET variants released by eosinophils and mast cells, expanding their immunological significance.
Application Areas
In clinical research, ETs serve as biomarkers for disease activity in rheumatoid arthritis and ANCA-associated vasculitis. Their quantification helps stratify patients for targeted therapies. Pharmaceutical companies explore ET inhibition strategies to mitigate damage in autoimmune disorders. Biotechnology leverages ET components to design novel antimicrobial coatings for medical devices. For example, histone-derived peptides from ETs show promise in combating antibiotic-resistant biofilms. Additionally, ET-modulating drugs are in trials for severe COVID-19 complications involving neutrophil hyperactivity.
Precautions
Handling ETs in lab settings requires biosafety level 2 precautions due to potential pathogen content. Researchers must use DNase-free reagents to prevent unintended ET degradation during experiments. In therapeutic contexts, unchecked ET formation may worsen atherosclerosis or thrombosis. Clinicians monitoring ET-related biomarkers should correlate findings with other inflammatory indicators to avoid misinterpretation. Commercial ET detection kits require validation against gold-standard microscopy methods.
B2B Procurement Guide
For research institutions, prioritize vendors offering validated anti-citrullinated histone H3 antibodies (Cit-H3), a specific ET marker. Bulk purchases of elastase or MPO detection kits may qualify for volume discounts. Manufacturers supplying ET study platforms should provide ISO 13485-certified products with batch consistency reports. Consider leasing high-content imaging systems for ET visualization rather than outright purchase due to rapid technological obsolescence. Collaborative projects may benefit from CROs specializing in neutrophil functional assays.
Related Manufacturers
- 主营：Elisa试剂盒、检测试剂盒
- 主营：elisa试剂盒
- 主营：ELISA试剂盒、高灵敏度试剂盒、试剂盒厂家、人ELISA试剂盒、小鼠ELISA试剂盒、大鼠ELISA试剂盒、仓鼠ELISA试剂盒、豚鼠ELISA试剂盒、鸡ELISA试剂盒、鸭ELISA试剂盒、牛ELISA试剂盒、羊ELISA试剂盒、马ELISA试剂盒、猴ELISA试剂盒、猪ELISA试剂盒、犬ELISA试剂盒、兔ELISA试剂盒、鱼ELISA试剂盒、植物ELISA试剂盒、土壤ELISA试剂盒、定性ELISA试剂盒、肿瘤标志物检测ELISA试剂盒、特种蛋白检测ELISA试剂盒、传染病检测ELISA试剂盒
- 主营：细胞试剂盒、Elisa试剂盒、生化试剂盒、蛋白试剂盒
- 主营：试剂盒、辅激活因子、elisa试剂盒、蛋白、多肽、金标试剂盒、PCR试剂盒、抗生素、氨基酸、血清、抗体
- 主营：elisa试剂盒
- 主营：elisa试剂盒、pcr检测试剂盒
- 主营：ELISA检测试剂盒、抗体、ELISA试剂盒
- 主营：脂蛋白、能受体、gla蛋白、磷脂酶、蛋白酶、酮戊二、p53诱导、样因子、大鼠iii、jo1抗体、p21蛋白、糖蛋白、大鼠肝、akt蛋白、磷酸酶、样蛋白、ca-mg-atp、双链dna、联蛋白、域蛋白、羟甲基、抗抗体、合成酶、前胶原、大鼠羧
- 主营：elisa试剂盒
- 主营：人elisa试剂盒、大鼠elisa试剂盒、小鼠elisa试剂盒、其他种属elisa试剂盒、植物elisa试剂盒、elisa试剂盒、elisa
- 主营：细胞、ELISA试剂盒、抗体、PCR试剂盒
- 主营：ELISA试剂盒、小鼠ELISA试剂盒、大鼠ELISA试剂盒、生化检测试剂盒、酶联免疫检测试剂盒、人ELISA检测试剂盒、植物检测试剂盒、兔ELISA试剂盒、猪elisa检测试剂盒、犬ELISA试剂盒、科研ELISA检测试剂盒
- 主营：科研试剂盒、酶免试剂盒、elisa试剂盒、细胞、生物试剂、进口ELISA试剂盒、PCR试剂盒、生化测试盒
- 主营：elisa试剂盒、分子生物学试剂及试剂盒、各种抗体及免疫学试剂盒